Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Sep 20;293(6549):728–731. doi: 10.1136/bmj.293.6549.728

Plasminogen activators in human colorectal neoplasia.

J S Gelister, M Mahmoud, M R Lewin, P J Gaffney, P B Boulos
PMCID: PMC1341448  PMID: 3094628

Abstract

A crucial step in the transition from adenomatous polyp to invasive colorectal cancer is the degradation of the epithelial basement membrane. Plasminogen activators may play a part in regulating the extracellular protease environment necessary for this to occur. Both functional and antigenic activity of the two principal activators of plasminogen, tissue plasminogen activator and urokinase, were measured in 30 colorectal cancers, matched samples of mucosa, and eight adenomatous polyps. Both polyps (p less than 0.01) and carcinomas (p less than 0.001) had raised urokinase activities compared with normal mucosa, the activity being highest in the carcinomas. Activity of tissue plasminogen activator, however, was diminished in both polyps (p less than 0.01) and carcinomas (p less than 0.001) compared with normal mucosa, the values being lowest in carcinomas. Plasmin generation by urokinase--in contrast with tissue plasminogen activator--is fibrin independent and thus less subject to physiological control.

Full text

PDF
728

Images in this article

730p730-a
on p.730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burtin P., Chavanel G., Andre J. The plasmin system in human colonic tumors: an immunofluorescence study. Int J Cancer. 1985 Mar 15;35(3):307–314. doi: 10.1002/ijc.2910350305. [DOI] [PubMed] [Google Scholar]
  2. CLIFFTON E. E., GROSSI C. E. Fibrinolytic activity of human tumors as measured by the fibrin-plate method. Cancer. 1955 Nov-Dec;8(6):1146–1154. doi: 10.1002/1097-0142(1955)8:6<1146::aid-cncr2820080610>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  3. Corasanti J. G., Celik C., Camiolo S. M., Mittelman A., Evers J. L., Barbasch A., Hobika G. H., Markus G. Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification. J Natl Cancer Inst. 1980 Aug;65(2):345–351. [PubMed] [Google Scholar]
  4. Durdey P., Cooper J. C., Switala S., King R. F., Williams N. S. The role of peptidases in cancer of the rectum and sigmoid colon. Br J Surg. 1985 May;72(5):378–381. doi: 10.1002/bjs.1800720515. [DOI] [PubMed] [Google Scholar]
  5. Friedman E., Urmacher C., Winawer S. A model for human colon carcinoma evolution based on the differential response of cultured preneoplastic, premalignant, and malignant cells to 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1984 Apr;44(4):1568–1578. [PubMed] [Google Scholar]
  6. Gelister J. S., Boulos P. B., Mahmoud M., Gaffney P. J. Proteinase-like peptidase activities in malignant and non-malignant gastric tissue. Br J Surg. 1986 Jan;73(1):84–84. doi: 10.1002/bjs.1800730144. [DOI] [PubMed] [Google Scholar]
  7. Granelli-Piperno A., Reich E. A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med. 1978 Jul 1;148(1):223–234. doi: 10.1084/jem.148.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Granelli-Piperno A., Reich E. Plasminogen activators of the pituitary gland: enzyme characterization and hormonal modulation. J Cell Biol. 1983 Oct;97(4):1029–1037. doi: 10.1083/jcb.97.4.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hinuma S., Honda S., Tsukamoto K., Sugamura K., Hinuma Y. Production of plasminogen activators by human T-cell leukaemia virus-transformed human T cell lines. Br J Cancer. 1985 Jun;51(6):753–759. doi: 10.1038/bjc.1985.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Juhan-Vague I., Moerman B., De Cock F., Aillaud M. F., Collen D. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thromb Res. 1984 Mar 1;33(5):523–530. doi: 10.1016/0049-3848(84)90018-5. [DOI] [PubMed] [Google Scholar]
  11. Kohga S., Harvey S. R., Weaver R. M., Markus G. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res. 1985 Apr;45(4):1787–1796. [PubMed] [Google Scholar]
  12. Liotta L. A., Goldfarb R. H., Brundage R., Siegal G. P., Terranova V., Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981 Nov;41(11 Pt 1):4629–4636. [PubMed] [Google Scholar]
  13. Malone J. M., Wangensteen S. L., Moore W. S., Keown K. The fibrinolytic system. A key to tumor metastasis? Ann Surg. 1979 Sep;190(3):342–349. doi: 10.1097/00000658-197909000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. O'Grady R. L., Upfold L. I., Stephens R. W. Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator. Int J Cancer. 1981 Oct 15;28(4):509–515. doi: 10.1002/ijc.2910280418. [DOI] [PubMed] [Google Scholar]
  15. Peterson H. I., Kjartansson I., Korsan-Bengtsen K., Rudenstam C. M., Zettergren L. Fibrinolysis in human malignant tumours. Acta Chir Scand. 1973;139(3):219–223. [PubMed] [Google Scholar]
  16. Rijken D. C., van Hinsbergh V. W., Sens E. H. Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay. Thromb Res. 1984 Jan 15;33(2):145–153. doi: 10.1016/0049-3848(84)90175-0. [DOI] [PubMed] [Google Scholar]
  17. Szczepański M., Lucer C., Zawadzki J., Tołoczko T. Procoagulant and fibrinolytic activities of gastric and colorectal cancer. Int J Cancer. 1982 Sep 15;30(3):329–333. doi: 10.1002/ijc.2910300312. [DOI] [PubMed] [Google Scholar]
  18. Tissot J. D., Hauert J., Bachmann F. Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas. Int J Cancer. 1984 Sep 15;34(3):295–302. doi: 10.1002/ijc.2910340302. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES